Annual Drug Patent Expirations for ENTRESTO
Entresto is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug.
Drug patent litigation for ENTRESTO.
This drug has forty-four patent family members in thirty-one countries.
The generic ingredient in ENTRESTO is sacubitril; valsartan. Two suppliers are listed for this compound. Additional details are available on the sacubitril; valsartan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
